Short Communication Open Access
Volume 2 | Issue 2 | DOI: https://doi.org/10.33696/haematology.2.026
Chemotherapy Promotes Release of Exosomes Which Upregulate Cholesterol Synthesis and Chemoresistance in AML Blasts
Chang-Sook Hong1, Michael Boyiadzis2, Theresa L. Whiteside1,3,*
- 1Department of Pathology, University of Pittsburgh and UPMC Hillman Cancer Center, Pittsburgh, PA 15213, USA
- 2Department of Hematology, University of Pittsburgh and UPMC Hillman Cancer Center, Pittsburgh, PA 15213, USA
- 3Department of Immunology, University of Pittsburgh and UPMC Hillman Cancer Center, Pittsburgh, PA 15213, USA
Corresponding Author
Theresa L. Whiteside, whitesidetl@upmc.edu
Received Date: April 09, 2021
Accepted Date: April 22, 2021
Hong C-S, Boyiadzis M, Whiteside TL. Chemotherapy Promotes Release of Exosomes Which Upregulate Cholesterol Synthesis and Chemoresistance in AML Blasts. J Clin Haematol. 2021; 2(2): 36-39.
Copyright: © 2021 Hong C, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Exosomes, PD-L1 and aGvHD: Perspectives for WJMSCmediated Therapy
Tumor-derived small extracellular vesicles or exosomes which carry the checkpoint PD-L1 are directly involved in immune evasion and uncontrolled tumor growth. We have recently reported that PD-L1 is also enriched on Wharton’s Jelly Mesenchymal Stromal Cell (WJMSC)-associated exosomes.
Effect of Exosomes on Alzheimer’s Disease
AD is a neurodegenerative disease characterized by progressive cognitive impairment, behavioral changes, memory loss and executive dysfunction, all of which present serious threats to the health of older people.
Chemotherapy Promotes Release of Exosomes Which Upregulate Cholesterol Synthesis and Chemoresistance in AML Blasts
Extracellular vesicles (EVs) are emerging as a key mediator of intercellular communication as well as a major mechanism of functional reprogramming of cells in disease. All cells produce EVs, which freely circulate and are found in all body fluids. EVs are heterogenous, consisting of subsets of vesicles with different sizes, distinct origins, and various functions (Figure 1). They mediate a broad variety of biological events ranging from cellular activation, inflammation, blood coagulation, angiogenesis, cellular transport, and others. Among these vesicles, a subset of small EVs (30-150 nm in diameter) originating from multivesicular bodies (MVBs) in parent cells and referred to as small extracellular vesicles (sEVs) carry proteomic, genomic and functional signatures that resemble those of parent cells and are, therefore, taken as surrogates of parent cells. In cancer, tumor-derived exosomes (TEX) reflect characteristics of tumor cells and are considered candidates for “liquid tumor biopsy”. Emerging evidence shows that TEX are a major sEV subset in plasma of patients with cancer, including hematologic malignancies.
Commentary on “Osteosarcoma from the Unknown to the Use of Exosomes as a Versatile and Dynamic Therapeutic Approach”
This commentary mentions to our published article that intends to describe the properties that turn exosomes (Exo) into an efficient, as well as safe nanovesicle for drug delivery and treatment of osteosarcoma (OS). Nowadays, the results of conventional treatments are still unsatisfactory, mainly, in patients with recurrent disease or metastatic.